GlaxoSmithKline cozies up to Five Prime for respiratory R&D

Damian Garde GlaxoSmithKline, facing widespread scrutiny for its underperforming respiratory business, has expanded its relationship with Five Prime Therapeutics, digging in to discover ...

New scrutiny for GlaxoSmithKline after news of 2001 bribery-related housecleaning in China

Carly Helfand GlaxoSmithKline's bribery woes in China apparently go back a bit further than the $ 489 million scandal that broke last summer. The U.K. company has acknowledged ...

GlaxoSmithKline and Theravance eye Phase III for another COPD contender

Damian Garde The blockbuster duo of GlaxoSmithKline and Theravance are pushing a new respiratory combo therapy into late-stage study, pooling the active ingredients from its last two ...

GlaxoSmithKline picks up FDA approval for its latest COPD contender

Damian Garde Adding to its string of respiratory victories, GlaxoSmithKline won an FDA nod for Incruse Ellipta, a once-daily COPD inhaler. FierceBiotech News

GlaxoSmithKline wins an FDA nod for its GLP-1 diabetes drug albiglutide

Damian Garde After a three-month delay pushed pause on its commercial plans, GlaxoSmithKline has secured FDA approval for albiglutide, a new diabetes treatment that will contend for ...

GlaxoSmithKline pulls all U.S. alli supplies, launches product-tampering probe

Carly Helfand GlaxoSmithKline is recalling supplies of its OTC weight-loss drug alli in light of reports from U.S. consumers who found the wrong drug when they opened their bottles. FiercePharma ...

GlaxoSmithKline eyes rare disease to widen its respiratory lead

Damian Garde GlaxoSmithKline is looking to deepen its respiratory pipeline with another late-stage trial of the injectable mepolizumab, this time studying the drug's effects in ...

GlaxoSmithKline wins FDA ‘breakthrough’ tag for malaria treatment

Damian Garde GlaxoSmithKline has picked up the FDA's coveted "breakthrough therapy" designation for its investigative malaria candidate, news that could shave months off ...

GlaxoSmithKline bags FDA approval for blockbuster COPD contender

Damian Garde GlaxoSmithKline and Theravance scored another victory through their profitable partnership, winning FDA approval for Anoro Ellipta, a trailblazing COPD combo therapy with ...

GlaxoSmithKline politely dumps $230M Fabry drug deal with Amicus

John Carroll Slightly less than a year after GlaxoSmithKline and Amicus Therapeutics reported that the first step in their Phase III program for the Fabry disease drug Amigal–or ...

GlaxoSmithKline to seek EMA approval for 2015 malaria vaccine launch

Tracy Staton It offers enough protection to slash the number of cases in infants for a time, a new study shows. FiercePharma News

GlaxoSmithKline weighs RBS chair to replace board chief Gent

Tracy Staton The parade of new pharma board chairs is growing longer. GlaxoSmithKline is reportedly eyeing Sir Philip Hampton, now chairman at Royal Bank of Scotland, to take up where ...
Page 2 of 712345...Last »
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS